Tumor-specific surface marker–independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry is a research paper published in Journal of Clinical Investigation (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of North Carolina
Grant: UNC Research Initiative Grant
National Institutes of Health
Grant: R01HL155098
National Institutes of Health
Grant: 5. R01 EB25651-01A1
National Institutes of Health
Grant: 5P50CA058223-12
SPORE in Breast Cancer
National Science Foundation
Grant: 1542015
NNCI: North Carolina Research Triangle Nanotechnology Network (RTNN)
National Institutes of Health
Grant: 5R01EB025651-04
Targeting through Selective Cell Labeling
National Institutes of Health
Grant: 5T32CA196589-09
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
National Institutes of Health
Grant: 3P30CA016086-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01HL155098-02
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
FWCI
1.19
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals